STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | 0.0% | 180 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 180 | +125.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 80 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 80 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 80 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -85.7% | 80 | -83.1% | 0.00% | – |
| Q2 2018 | $7,000 | 0.0% | 474 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | -95.6% | 474 | -95.4% | 0.00% | -100.0% |
| Q4 2017 | $160,000 | +33.3% | 10,274 | -4.6% | 0.00% | +100.0% |
| Q3 2017 | $120,000 | +2.6% | 10,774 | -15.1% | 0.00% | 0.0% |
| Q2 2017 | $117,000 | +7.3% | 12,694 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $109,000 | -19.9% | 12,694 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $136,000 | +806.7% | 12,694 | +810.6% | 0.00% | – |
| Q3 2016 | $15,000 | +66.7% | 1,394 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | +50.0% | 1,394 | 0.0% | 0.00% | – |
| Q1 2016 | $6,000 | -33.3% | 1,394 | 0.0% | 0.00% | – |
| Q4 2015 | $9,000 | -25.0% | 1,394 | 0.0% | 0.00% | – |
| Q3 2015 | $12,000 | -25.0% | 1,394 | 0.0% | 0.00% | – |
| Q2 2015 | $16,000 | +14.3% | 1,394 | +39.4% | 0.00% | – |
| Q1 2015 | $14,000 | -17.6% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $17,000 | +41.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $12,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $15,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|